Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
Related Questions
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
When do you consider ambulatory EEG to assess for future seizure risk in someone with seemingly resolved acute symptomatic seizures?
How often do you consider lamotrigine in patients with myoclonic epilepsy?
What is the role for inpatient limited-montage EEG recording?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
When do you use seizure prophylaxis in patients on clozapine?
Besides patient preference, what factors guide your decision to treat SeLECTs patients with antiseizure medications?
